A research team from the Hospital Clínic-IDIBAPS, the Catalan Institute of Oncology (ICO) and the Vall d’Hebron Institute of Oncology (VHIO) has participated in an international study that demonstrates the efficacy of a new drug for metastatic breast cancer with low expression of HER2, the protein found on the outside of tumor cells. This treatment, [...]
The Hospital Clínic de Barcelona-IDIBAPS has developed a new CAR-T treatment for multiple myeloma, the second most common blood cancer, with encouraging results: “all patients improve, 75% of them maintain the response and not they have disease progression at 12 months, and 60% have complete remission without residual disease “, says Dr. Fernández de Larrea, [...]
